VeriChip Corporation has selected Raytheon Microelectronics España/ECLAN for the production of the company’s implantable microchips, including the chip used in its HealthLink patient identification system, its new eight millimeter microchip for use in Medical Components Inc.’s vascular access medical devices, and its glucose-sensing RFID microchip under development with RECEPTORS LLC.
In December 2008, VeriChip purchased all intellectual property related to its implantable RFID business line from Digital Angel Corporation and canceled its manufacturing relationship. After searching for a new manufacturing partner, VeriChip landed on ELCAN Optical Technologies, a provider of optical and electronic solutions for medical, defense & security and commercial customers, and part of the Raytheon Network Centric Systems group of companies.
Latest from Today's Medical Developments
- IMTS 2026 runs Sept. 14-19 at McCormick Place in Chicago, Illinois
- Master Bond’s MasterSil 800Med
- ZEISS celebrates 100 years of advancing innovation in the US
- Teleflex sells acute care and urology businesses for $2.03 billion
- HANNOVER MESSE: Where research and manufacturing meet
- What’s next for the design and manufacturing industry in 2026?
- Arcline to sell Medical Manufacturing Technologies to Perimeter Solutions
- Decline in German machine tool orders bottoming out
